Addus HomeCare Co. (NASDAQ:ADUS) Given Average Recommendation of "Buy" by Brokerages

Shares of Addus HomeCare Co. (NASDAQ:ADUS - Get Free Report) have received an average recommendation of "Buy" from the nine brokerages that are currently covering the firm, MarketBeat.com reports. Seven investment analysts have rated the stock with a buy recommendation and two have given a strong buy recommendation to the company. The average 12 month target price among brokers that have covered the stock in the last year is $139.00.

Several equities analysts recently issued reports on the company. JMP Securities restated a "market outperform" rating and set a $150.00 price objective on shares of Addus HomeCare in a research note on Tuesday, April 22nd. Stephens reiterated an "overweight" rating and set a $142.00 price objective on shares of Addus HomeCare in a research note on Wednesday, March 12th. Oppenheimer upped their target price on Addus HomeCare from $145.00 to $150.00 and gave the company an "outperform" rating in a report on Friday, January 24th. Macquarie reaffirmed an "outperform" rating and issued a $129.00 target price on shares of Addus HomeCare in a research report on Thursday, February 27th. Finally, StockNews.com downgraded shares of Addus HomeCare from a "buy" rating to a "hold" rating in a report on Wednesday, February 26th.

Institutional Investors Weigh In On Addus HomeCare

Several hedge funds and other institutional investors have recently added to or reduced their stakes in ADUS. Natixis raised its stake in shares of Addus HomeCare by 111.9% in the 4th quarter. Natixis now owns 250 shares of the company's stock worth $31,000 after buying an additional 132 shares in the last quarter. Smartleaf Asset Management LLC lifted its holdings in Addus HomeCare by 324.2% in the 4th quarter. Smartleaf Asset Management LLC now owns 280 shares of the company's stock valued at $35,000 after acquiring an additional 214 shares during the last quarter. Parkside Financial Bank & Trust boosted its position in shares of Addus HomeCare by 38.6% during the 4th quarter. Parkside Financial Bank & Trust now owns 531 shares of the company's stock valued at $67,000 after purchasing an additional 148 shares in the last quarter. Meeder Asset Management Inc. acquired a new position in shares of Addus HomeCare in the 4th quarter worth approximately $77,000. Finally, Harvest Fund Management Co. Ltd bought a new stake in shares of Addus HomeCare in the 4th quarter worth approximately $86,000. Institutional investors own 95.35% of the company's stock.

Addus HomeCare Price Performance

NASDAQ ADUS opened at $104.37 on Tuesday. Addus HomeCare has a 12 month low of $88.96 and a 12 month high of $136.72. The company has a market capitalization of $1.92 billion, a price-to-earnings ratio of 23.88, a price-to-earnings-growth ratio of 1.41 and a beta of 0.85. The company's fifty day moving average price is $97.64 and its two-hundred day moving average price is $114.80.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last issued its quarterly earnings results on Monday, May 5th. The company reported $1.42 EPS for the quarter, topping the consensus estimate of $1.33 by $0.09. Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. The business had revenue of $337.71 million for the quarter, compared to analysts' expectations of $341.66 million. During the same quarter last year, the company posted $1.21 earnings per share. The company's quarterly revenue was up 20.3% compared to the same quarter last year. As a group, analysts anticipate that Addus HomeCare will post 4.59 EPS for the current year.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.